The Gross Margin of Gan & Lee Pharmaceuticals (603087.SS) is 72.21%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 72.21% |
| 2022-12-31 | 76.30% |
| 2021-12-31 | 89.03% |
| 2020-12-31 | 90.88% |
| 2019-12-31 | 91.74% |
| 2018-12-31 | 92.15% |
| 2017-12-31 | 91.31% |